Literature DB >> 762083

Nonenzymatically glucosylated albumin. In vitro preparation and isolation from normal human serum.

J F Day, S R Thorpe, J W Baynes.   

Abstract

Incubation of human serum with D-[6-3H]glucose resulted in the gradual accumulation of radioactivity in acid-precipitable material. Upon chromatography on Sephadex G-200, radioactivity was found associated with each of the major molecular weight classes of serum protein. Purified human serum albumin was also glucosylated in vitro upon exposure to D-[6-3H]glucose in phosphate-buffered saline. The glucosylated and unmodified albumins were separated by ion exchange chromatography. The physiological significance of these observations in vitro was confirmed by the isolation and quantitation of glucosylated albumin from normal human serum. Glucosylated albumin represents approximately 6 to 15% of total serum albumin in normal adults. The post-translational modification appears to occur by a nonenzymatic process analogous to that responsible for glucosylation of hemoglobin A to hemoglobin AIc, i.e. through Schiff base formation and Amadori rearrangement to a ketoamine derivative.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 762083

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

Review 1.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

2.  Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides.

Authors:  Annunziata Lapolla; Domenico Fedele; Rachele Reitano; Nadia Concetta Aricò; Roberta Seraglia; Pietro Traldi; Ester Marotta; Roberto Tonani
Journal:  J Am Soc Mass Spectrom       Date:  2004-04       Impact factor: 3.109

3.  Basic performance of an enzymatic method for glycated albumin and reference range determination.

Authors:  Takuji Kohzuma; Tamotsu Yamamoto; Yumiko Uematsu; Zak K Shihabi; Barry I Freedman
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

Review 4.  Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).

Authors:  R Zini; P Riant; J Barré; J P Tillement
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

5.  Ribosylation of bovine serum albumin induces ROS accumulation and cell death in cancer line (MCF-7).

Authors:  Mohd Shahnawaz Khan; Sourabh Dwivedi; Medha Priyadarshini; Shams Tabrez; Maqsood Ahmed Siddiqui; Haseeb Jagirdar; Abdulrahman M Al-Senaidy; Abdulaziz A Al-Khedhairy; Javed Musarrat
Journal:  Eur Biophys J       Date:  2013-11-12       Impact factor: 1.733

6.  Glycosylated haemoglobin and plasma glycoprotein assays by affinity chromatography.

Authors:  D G Willey; M A Rosenthal; S Caldwell
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

7.  Structural and functional consequences of increased tubulin glycosylation in diabetes mellitus.

Authors:  S K Williams; N L Howarth; J J Devenny; M W Bitensky
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

8.  Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody.

Authors:  S Kume; M Takeya; T Mori; N Araki; H Suzuki; S Horiuchi; T Kodama; Y Miyauchi; K Takahashi
Journal:  Am J Pathol       Date:  1995-09       Impact factor: 4.307

9.  Non-enzymatic glycation of epidermal proteins of the stratum corneum in diabetic patients.

Authors:  I Márová; J Záhejský; H Sehnalová
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

10.  Evidence of changes in renal charge selectivity in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  A Kverneland; B Feldt-Rasmussen; P Vidal; B Welinder; L Bent-Hansen; U Søegaard; T Deckert
Journal:  Diabetologia       Date:  1986-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.